Abstract. Despite two decades of significant investments in R&D of Integrated System Health Management (ISHM), mission-critical applications of it in aerospace are few and far between. ISHM is subject to the general difficulty of transitioning technologies out of R&D labs and into practical applications. New and unproven methods such as ISHM introduce multiple mission risks (technology, schedule, cost), and may require a transition to unconventional and as-yet-unproven operations concepts in order to be effective. Laboratory and flight demonstrations are necessary but insufficient to adequately reduce those risks. What is needed is a solid business case before a new technology can be considered for fleetwide deployment. To address these problems, we recently applied a technology maturation assessment process developed at NASA's Jet Propulsion Laboratory to study the challenges of ISHM technology maturation. This application resulted in identification of the technologies (and technology maturation activities) that would result in the greatest risk reduction per investment dollar. Our approach and its results are described herein.
INTRODUCTION
Integrated System Health Management (ISHM) is the discipline of health management for systems in general, encompassing the processes, techniques and technologies used to design, analyze, build, verify, and operate complex human-machine systems with the goal of preventing failures or minimizing their effects. The U.S. government has invested several hundred million dollars in basic and applied ISHM research and development over the last couple of decades. Yet, mission-critical applications of ISHM in aerospace are few and far between. Forms of ISHM have been utilized to good effect on the logistics end of the lifecycle (often referred to as "condition-based maintenance") for platforms such as the C-17 (Pace, Negron and Erickson, 1997) . But in other areas that would appear ripe for utilization of ISHM, such as extending the functionality of fault protection to both scale to more complex systems (and systems of systems), and more generally for maintaining capability rather than just averting catastrophe, uptake has been meager.
Approaches such as the NASA-developed "Technology Readiness Level" (TRL) (Mankins, 1995) , and modifications of it specifically for information technologies (Mackey, Some and Aljabri, 2003) , give us ways to measure/assess the status of technologies with respect to their maturation. As a discipline, ISHM is at the "mid-TRL" stage (depending on the specific technology, somewhere in the TRL 4 -7 range). Crossing this range is widely perceived as challenging for many kinds of technologies -indeed, it is evocatively referred to as the "valley of death" because of the disappointingly low frequency of success. Lack of funding for mid-TRL activities is often cited as the culprit, but there is good reason to believe that this is but one of many dynamics that can inhibit successful transition. New and unproven technologies introduce multiple project risks (technology, schedule, cost) . An equally important issue is that many new technologies require unconventional, unproven operations concepts in order to be effective. Finally, new technologies often require solid business cases to be considered for fleetwide deployment. Laboratory and flight demonstrations are necessary steps to take, but alone are inadequate to sufficiently reduce these risks.
In recent years, NASA's Jet Propulsion Laboratory (JPL) has developed a process for identifying, and planning for the reduction of, technology maturation project risks. The process identified the technologies (and technology maturation activities) that result in the greatest risk reduction per investment dollar. The process, called "Technology Infusion Maturity Assessment" (TIMA), has been applied to a number of aspiring technologies, and is capable of producing grounded insights into technology investment strategies that result in safer and more costeffective NASA missions (Feather, Cornford, Hicks and Johnson, 2005) .
We recently used the TIMA process to define a maturation and deployment path for opportunities to use several NASA ISHM technologies. The objectives of this paper are to describe the key aspects of this process and its application, yielding information of help to the decision-makers in selecting which technology opportunities to pursue, and how to go about their pursuit. The sections that follow give background information on ISHM, summarize the TIMA process, and show how its application led to insights on the technology maturation challenges and guided identification of infusion steps we should take to reduce technology risk for those ISHM deployments.
INTEGRATED SYSTEM HEALTH MANAGEMENT (ISHM) BACKGROUND
As a guide to readers not familiar with ISHM, The following is derived from Johnson's paper goes on to describe the evolution of ISHM from the so-called "Vehicle Health Monitoring (VHM)" work within the NASA research community in the early 1990s. The focus of the early VHM effort was on selection and use of sensors and software to monitor the health of space vehicles. Engineers then extended the scope to also take into consideration what actions to take based on the parameters monitored, and to apply it to not just vehicles, but complex human-machine systems in general. "System Health Management" became the preferred moniker. Johnson also describes the influence from similar work taking place under the auspices of the Department of Defense under the title "Integrated Diagnostics." The DoD focus was operational maintenance issues (usually in an aircraft environment). Detecting and responding to faults often led them to require "integrated" diagnostics looking at many aspects of the vehicle in question. This word made its way into the preferred NASA terminology, yielding "Integrated System Health Management" (ISHM). This helped emphasize how ISHM spanned entire systems, not merely fault protection within distinct subsystems. Finally, Johnson relates how the organizers of the Forum on Integrated System Health Engineering and Management in the Fall of 2005 decided to add the word "Engineering" to the title, to distinguish between the technical and social aspects of the problem of preventing and mitigating failures. Readers seeking further information on ISH(E)M may examine the papers to be found in the proceedings from that Forum, currently available from http://ti.arc.nasa.gov/projects/ishem/papers_pres.php
TECHNOLOGY INFUSION MATURITY ASSESSMENT (TIMA) BACKGROUND
The "Technology Infusion Maturity Assessment" (TIMA) process has been developed and used for several years at JPL for assessing and planning the maturation of technologies. The motivation for developing a process to do this stems from previous JPL experience suggesting that the rate at which new technology is infused into new space exploration missions has room for significant improvement. An informal survey conducted at JPL indicated that the predominant reasons for low technology infusion rates were: 1) customer (mission) requirements were either miscommunicated, misunderstood, or under-defined, 2) the technology was deemed non-flightworthy in its current state of development (i.e., the technology was not considered for infusion into the flight design because of some unforeseen engineering issues), and 3) other nearly-equivalent commercially-available technologies could possibly replace NASA-developed technologies. From these findings, it could be inferred that technology infusion rates might be improved by clearer definition of the mission requirements, earlier addressing of the technology-specific engineering difficulties that may result from alternative technology/mission architecture decisions, and a better understanding of the projected status of the development of competing technologies from the present to the estimated time of delivery.
The TIMA process was developed to help perform these steps and so aid technology infusion. It makes use of a methodology initially conceived as an aid to quality assurance planning (Cornford, 1998) , and which has subsequently been used for project risk assessment throughout projects' lifecycles (Cornford, Feather and Hicks, 2001) . By viewing obstacles to technology infusion as "risks" (potential future events which, should they occur, will impede infusion), the methodology becomes applicable to assessing and planning the infusion of technologies, and over the last few years TIMA studies have formed the majority of the applications of this methodology (Feather, Cornford, Hicks and Johnson, 2005) .
The process takes place in a series of facilitated sessions, each typically several hours in duration, during which all participants are present. They contribute the information pertinent to the study, and perform decision making on the basis of that assembled information. Custom software is used to store the information as it is elicited, perform calculations on the assembled information, and present the information to the participants through cogent visualizations. It is also used to generate material for inclusion in the documentation at the conclusion of the study.
The TIMA process, as applied in this study, captured and reasoned with the following information:
• "Missions" -the potential infusion targets for ISHM technologies,
• "Obstacles" -the factors that have potential to impede successful infusion of ISHM technologies into missions, and • "Actions" -the possible actions (over and above what would be the standard approach to such experiments) to take to overcome the obstacles, and so increase the likelihood of successful infusion of ISHM technologies into missions.
The ISHM experts provided lists of each of the above, and provided the following linkages among them:
• For each obstacle x mission pair, the experts provided an assessment of how much the obstacle would be expected to impede infusion of the ISHM technology onto the mission.
• For each obstacle x action pair, the experts provided an assessment of how much the action would overcome the infusion impediments represented by that obstacle.
The assemblage of this information allows for the following calculation:
For a specific mission and selection of actions, computation of the magnitudes of the obstacles to ISHM infusion into that mission, taking into account the extent to which the selected actions overcome infusion obstacles.
This is key information in guiding the selection of which mission opportunities to pursue. Missions for which there are many obstacles that cannot be overcome, or can only be overcome at high cost (recall that the costs of the actions have been assessed), would be risky and/or expensive to pursue. Note that this reveals not only the overall extent of a mission's infusion obstacles, but also the status of the specific obstacles (e.g., they can be scrutinized in descending order of magnitude). As will be seen in later sections, bar charts are a useful means to cogently present this information.
These calculations are also key to guiding the selection of which actions to perform should a given mission opportunity be pursued. Again, bar charts serve as a convenient format for revealing the contributions that individual actions make to overcoming infusion obstacles.
There are obviously many different ways of selecting from a set of actions, and some selections will be superior to others (costing less to overcome just as many obstacles, or overcoming more obstacles for the same cost). The software that supports the TIMA process is able to help in the search for "optimal" selections (e.g., ones that, for a given cost ceiling, maximally overcome infusion obstacles). More details on this use of optimization are discussed in (Cornford, Feather and Dunphy, 2002) .
It is also the case that, generally speaking, the more of the actions that can be afforded, the more obstacles can be overcome. Thus there is a cost-obstacle trade-off. The software that supports the TIMA process is able to help reveal the "shape" of this trade space.
STUDY PURPOSE AND SCOPE
The overall purpose of the study was to prioritize and select technology maturation opportunities given limited resources (technology maturation funds as well as ISHM experts). The initial scope of the study was a list of 21 mission opportunities thought to be potential targets for infusion of ISHM technologies. Realizing that it would be too onerous to consider all 21 in depth, the study began by narrowing the list to the following 7, based on plausibility of intent to pursuing the opportunity. The target missions varied substantially in terms of their maturity levels, customers, and overall budget. The chosen seven, described below (but for sensitivity reasons we do not give their actual names), received the in-depth scrutiny afforded by the TIMA process:
1. Data from the flight of a launch vehicle would be analyzed using ISHM technology after the flight was over. 2. Data during a launch vehicle's preflight checkout period would be analyzed in real-time using ISHM technology. 3. Data would be monitored and analyzed during flight of a launch vehicle by ISHM algorithms executing on a dedicated on-board computer, with outputs written to a data recorder for recovery from the first stage in the ocean, 4. ISHM in a ground-based fault prediction console would help with the ground testing of a lunar spacecraft through Assembly Test and Launch Operations (ATLO), and during flight to monitor sensor readings so as to proactively identify problems. 5. An airborne facility capable of recreating Mars levels of gravity, temperature and atmospheric pressure.
6. An on-board active ISHM experiment on an earth-orbiting spacecraft -exercising of ISHM software (by deliberately commanding failure modes, etc) on an actual spacecraft once it has completed its primary mission. 7. Use of on-board active ISHM for fault protection on an earth-orbiting spacecraft, and, once the primary mission is complete, for more ambitious uses of ISHM including experiments on ISHM directing autonomous spacecraft control while faults are deliberately injected.
The TIMA study considered the obstacles that each of these experiments face, and identified actions that could be taken to help overcome these obstacles. In considering them, assessments were made on how much each of the obstacles impeded each of the missions, and by how much each of the actions would decrease each of the obstacles. The actions were also assessed for how much they would cost. This gathered information revealed the extent to which obstacles impede each of the mission experiments, and how much it would cost to perform the basic experiment plus the actions taken to decrease those obstacles.
It is important to note that this study focused on only the obstacles to ISHM mission experiments. Selection of which mission experiment(s) to pursue must also take into account the merits of those experiments. In the interests of expediency, the TIMA study did not attempt to model or otherwise assess such merits. The feeling was that far greater uncertainty lay in the obstacles and what could be done about them, and so those were to form the scope of the TIMA study.
STUDY OUTCOMES
The study outcomes were an understanding of: the key obstacles to ISHM technology maturation on each of the seven missions, recommended selections of actions (over and above normal practice) to take to overcome those obstacles, and the extent to which obstacles will be overcome varies as more or less is expended on those additional actions. As stated above, the seven mission opportunities for ISHM technologies were scrutinized from the point of view of obstacles to success; selection from among those opportunities should also take into account the relative benefits of those opportunities.
Overall outcome
The overall outcome of the TIMA study is a comparative understanding, across the seven missions, of the cumulative status of the obstacles to ISHM technology maturation on each of those missions. Furthermore, the extent to which those obstacles can be overcome, by suitable investments in actions above and beyond those normally planned for ISHM developments, is also revealed.
These overall outcome results are shown graphically in a plot generated from the information gathered in the TIMA study, seen in Figure 1 . This plot shows the shape of the trade space between Total Obstacles and Total Cost for each of the seven mission opportunities. Each mission opportunity is represented as a line on the chart, plotted with respect to two axes -the vertical axis represents sum total of obstacles, horizontal axis represents cost. For points on the lines, the higher vertically they are, the more the assessed Total Obstacles -i.e., undesirable. Likewise, the further right they are, the more the Total Cost -i.e., also undesirable. As one might expect, as more is spent on actions to overcome obstacles, the cost increases, and obstacles are decreased. The horizontal segment that starts each such line represents the baseline cost of that experiment. Beyond that, the lines descend as they extend rightwards, indicating the contributions to be had from spending additional funds (over and above the baseline cost of the experiment) on specific obstacle-overcoming actions. Note: these lines represent the optimal way to expend additional funds on additional obstacle-overcoming actions -we discuss later how we have arrived at these. The horizontal scale is in units of thousands of dollars -so for example, the lines for missions #6 and #7 make steep descents at approximately the $2M to drop to roughly the same obstacle level, however #7 has a second (smaller but still discernable) drop at approximately the $4M level. The vertical scale is in artificial units of "obstacles" -a measure proportional to the difficulties that an ISHM technology will potentially encounter if attempted as that mission experiment. The preliminary nature of the information we put into the TIMA process means that we make no claim to yield a "probability of success" number. The guidelines we ascribe to the absolute values are at best as coarse indicators of concern -we would like to see lines fall below the 1 level, (relatively low on the chart at its current scale); the 1 -2 region indicates that some troublesome concerns linger, etc. The purpose of this chart is to give the overall view into the tradespace; details of the status of the specific obstacles that threaten mission experiments will be shown by other means. 
Recommendations of Prudent Approaches
Towards the end of the study (i.e., after having completed the gathering of information on obstacles and potential actions to overcome them) the study team examined the seven mission opportunities and, guided by the gathered information, made a selection of a recommended way to proceed for each of those seven missions. They termed these recommendations "prudent", to reflect that in arriving at them, they had made a judicious choice of the balance between cost and benefit (reduction of obstacles). As they made their deliberations, the team took into account the plausibility of finding sufficient time, personnel and funding to enact the set of actions that corresponded to each recommendation. The process for doing so was as follows:
• Infusion obstacles were considered in decreasing order of their expected magnitude, stopping when all the remaining obstacles were of sufficiently low magnitude.
• For each obstacle, actions were selected if they were effective (i.e., had a significant effect at overcoming that obstacle) and cost no more than approximately $100K. Note that an action may simultaneously help overcome multiple obstacles, a phenomenon that the software supporting the TIMA process makes visible to the experts.
• After selecting all such low-cost actions, more expensive actions were added to the selection only if highly effective, and only if they addressed critical obstacles that the experts felt could not be left outstanding.
There is some element of judgment in this decision; it is possible to arrive at different selections under different interpretations of the right trade-off to make between cost and expectations of success.
The placement of these "prudent" selections with respect to the trade space chart is shown in Figure 2 
Detailed Status of Prudent Approaches
Figures 1 and 2 presented overview information, where a progression of increasingly effective yet expensive action selections have been abstracted into lines that reflect their summary values (namely, cost and remaining obstacles). Considerable further detail lies behind these lines. Of particular interest are details of the "prudent" approaches. Table 1 gives further insight into these details. From left to right, the columns of this table are: the mission experiment, the total cost, i.e., adding together the baseline experiment cost and the cost of the recommended set of additional action (expressed in thousands of dollars), the duration (in years), the total cost per year (also expressed in thousands of dollars), and the concise names of the significant maturity obstacles remaining after taking into account the anticipated beneficial effects of the recommended set of prudent actions. 
DETAILS OF THE TIMA PROCESS
As discussed earlier, this study started from a list of 21 potential mission opportunities for infusion of ISHM technologies, and narrowed to seven for in-depth scrutiny. The TIMA process calls for the following steps:
• List the "Obstacles" -the factors that have potential to impede successful infusion of ISHM technologies into missions. For each obstacle x mission pair, assess how much the obstacle would be expected to impede infusion of the ISHM technology onto the mission.
• List the "Actions" -the possible actions (over and above what would be the standard approach to such applications of ISHM) to take to overcome the obstacles, and so increase the likelihood of successful infusion of ISHM technologies into missions. For each obstacle x action pair, assess how much the action would overcome the infusion impediments represented by that obstacle.
• Use the TIMA software to scrutinize the aggregation of the above information, in order to provide guidance to for decision making (e.g., in our study to help guide determination of the "prudent" selections of actions).
Technology Obstacles
The first step of the TIMA process is to list the potential obstacles to ISHM technology use on those seven missions.
Obstacles included those relevant to many of the missions, and those specific to particular missions. For each obstacle x mission pair, the study team provided an assessment of how much the obstacle would be expected to impede infusion of the ISHM technology onto the mission. This information is key to differentiating between the different infusion opportunities. The TIMA process allows for the option of separately assessing the likelihood that an obstacle will materialize, and its severity (i.e., impedance to infusion) should it materialize, however the decision was made in this study to capture only a single value, the product of these (i.e., the expected magnitude of impedance to infusion).
Information of this nature is most easily presented as a spreadsheet. The top portion only (in the interest of saving space) of the spreadsheet is shown in Table 2 . 
Missions
The columns of this table are the seven missions, the rows the obstacles thought to have the potential to impede infusion of ISHM technologies into those missions (only the first 10 obstacle rows are shown). The numeric entries in the cells at the intersections of these rows and columns indicate the estimated magnitude (likelihood x severity) of the impedance, expressed as a number in the range 0 to 1.0. An empty cell is equivalent to a value of zero. A value of 1.0 would mean certainty of total impedance, i.e., the obstacle (assuming nothing special is done about it) would completely impede success of ISHM technology maturation in that mission experiment. Lesser values mean a correspondingly lesser expectation of impedance. In the interests of expediency, the study team offered only expected values (i.e., what would result by multiplying likelihood and severity). For example, a value of 0.3, could mean a 0.3 likelihood of complete impedance, a certainty of 0.3 impedance (you'd only get some success), or combinations in-between. In principle the TIMA methodology (and the software that supports it) allows for capturing the distinction between likelihood and severity, but to do so takes additional time and effort to elicit more detailed information, and the study team judged it sufficient to work with expected values.
Note that the numbers are to only very coarse precision. This is characteristic of TIMA studies. When attempting to make assessments of future situations with elements of significant novelty, experts' estimates are often the best information available. When this is the case (as holds for the ISHM study), participants are only asked to make distinctions to this level of granularity. For this reason the outcome of a TIMA study may well provide guidance useful to making choices, but should not be interpreted as a prediction of likelihoods. For example, this study helps show how obstacles to ISHM infusion "add up" against each of the missions, and so helps to understand the ramifications of choosing one mission over another; it also indicates which actions are effective at overcoming (to some extent) those obstacles. However, this study does not yield specific likelihood predictions such as "technology infusion into this mission has a 0.95 likelihood of success."
Potential Actions to Overcome Obstacles
Having elicited the obstacles to ISHM technology infusion, the next step of the TIMA process had the study team list potential actions (over and above what would be normal practice) to take to help overcome those obstacles. For each action x obstacle pair, the study team provided an assessment of how effective the action would be at overcoming the obstacle. Furthermore, the study team assessed the cost of performing each action -this is why we refer to "potential actions", because budget and other factors limit how much can be expended on these actions.
Information of this nature is also most easily presented as a spreadsheet. The top portion only (in the interest of saving space) of the spreadsheet is shown in Table 3 . The columns of this table are some of the potential actions, the rows the same obstacles as listed earlier (again, only the first 10 obstacle rows are shown). The numeric entries in the cells at the intersections of these rows and columns indicate the estimates of each action's effectiveness at overcoming each obstacle, expressed as proportions. For example, the effectiveness of an action that would completely overcome an obstacle would be the value 1.0, whereas the effectiveness of an action that only overcame an obstacle 7 times out of 10 (or always overcame 70% of that obstacle), would be the value 0.7. An empty cell is equivalent to a value of zero, i.e., no effect at reducing the obstacle. Note again that as for the table of obstacles' impediments to infusion, the numbers are to only very coarse precision.
The above table lists action effects when it was judged that the effect would be the same regardless of which mission it was. When the team considered that an action's effect on overcoming an obstacle varied depending on which mission was involved, such distinctions were captured.
Finally, for each action the study team assessed the cost of that action. In doing so they made the distinction between actions that would have to be paid for only once, and thereafter every mission would benefit from the obstaclereducing effects of that action, and those that would have to be paid for on a mission-by-mission basis. This distinction becomes important when considering selecting several of the seven missions at once as infusion targets.
Calculating the Net Effect of Action Selections
Having collected the information on obstacles and actions to overcome them, it is possible to use the software that supports TIMA to perform various calculations in terms of that collected information. The essence of these calculations is to take as input a selection from among the actions, compute by how much that selection of actions overcomes the obstacles, and from that compute how much the remaining obstacles still impede successful infusion of ISHM onto each mission. The cost of that selection of actions is also computed.
Briefly, the underlying TIMA model assumes that multiple obstacle fractions against the same mission simply add up. For example, if two obstacles have values of 0.1 and 0.3 against the same mission, they add up to a combined obstacle of 0.4. The model assumes that multiple actions against the same obstacle act like a series of "filters", each in turn removing some proportion of the obstacle as indicated by the effect value. For example, if two actions with values 0.3 and 0.4 act against the same obstacle with initial value of 1.0, the first one reduces it by the fraction 0.3, i.e., reduces 1.0 is reduced to 0.7, and the second one further reduces that 0.7 by the fraction 0.4, i.e., reduces 0.7 to 0.42 (0.7 -(0.4 x 0.7)). For further explanation and commentary on the underpinnings of TIMA's calculations, see (Cornford, Feather and Hicks, 2001 ).
Several useful values can be calculated in terms of the above:
• The total of the obstacles against each mission.
• Each specific obstacle's contribution to impeding ISHM infusion on a mission.
•
The total of the obstacles' impediments against each mission.
The total cost of a selection of actions.
The obstacle-reducing effects of an action.
TIMA's software performs these calculations automatically, and uses several forms of visualization to present the results to the study team and to generate charts for inclusion in reports documenting the study, discussed next.
Scrutinizing the Net Effect of Action Selections
Some of the detailed values are cogently presented by means of straightforward bar charts, generated by the TIMA software. For example, Figure 3 shows a portion of the bar chart of the status of obstacles against the #1 Mission (postflight analysis of data from a launch vehicle). Each row of the chart corresponds to one of the obstacles, the name of which is on the right, and the status of which is indicated by how far to the left the grey and black bars extend. The bars indicates the extent that obstacle impedes ISHM success on the mission in question -the grey bar indicates what this value would be were no actions selected, the black bar indicate what the value would be would the current selection of actions adopted. The scale (a log scale, note) is indicated along the bottom. A zero in place of bars means the obstacle was irrelevant to the mission in question.
In this figure, the selection of actions is the so-called "prudent" selection that the study team made for this mission. The rows have been sorted in descending order of the black bars' lengths, so the topmost row indicates the greatest obstacle remaining despite the "prudent" action selection. Its title, "ISHM Experiment is a failure (without necessarily causing flight failure)" refers to the very real possibility that the mission will go fine (indeed we hope that this will be the case), and as a result the ISHM algorithms will have only nominal data to analyze. This would do little to increase confidence that the ISHM algorithms would correctly detect dangerous off-nominal conditions, or that they would not be incorrectly triggered during unusual but non-dangerous conditions -both major concerns.
We use a similar bar chart style to show the status of the actions in the selection of actions. However, note that different actions have different costs. In making a selection of a set of actions it is obviously necessary to take cost into account. Furthermore, since a single action may help reduce multiple obstacles, and since a single obstacle may be potentially reduced by multiple actions, it can be complicated to arrive at a cost-effective selection. The TIMA software can help by automatically exploring the space of possible action selections, and presenting summary results such as those seen earlier in Figures 1 and 2 . These were automatically generated by considering a large number of selections of actions. Each selection was abstracted to its two key measures -total of obstacles' impedance against the ISHM experiment on the mission, and total cost of the selected actions, and plotted as a point on a chart whose axes are cost and obstacles. From this the software derived the so-called "Pareto frontier", the line that demarks the optimal points -(for different cost levels, the ways to most effectively select actions to maximally reduce obstacles).
The lies plotted in Figures 1 and 2 were the "Pareto frontiers" for the seven missions studied in depth. 
CONCLUSION
Technology maturation is a complex, expensive, and ill-understood process. Due to large investments in the 1990s and 2000s by NASA and the Department of Defense, several ISHM-related technologies have been developed and matured to mid-TRL levels. Flight maturation opportunities for mid-TRL technologies are relatively rare, and when such opportunities emerge, it is imperative to follow a rational decision process in order to maximize the chance of success. In this paper, we outlined the use of the TIMA process as a means to reach such rational decisions regarding ISHM technology maturation opportunities. Even though the process is not specific to ISHM, the multifaceted, multi-disciplinary nature of ISHM lends itself particularly well to analysis using a multi-objective optimization approach such as TIMA. As a minimum, the utilization of a rational decision process forces the technology maturation team to explicitly define and discuss the risks, costs associated with retiring those risks, and whether the costs justify the outcomes. In the case of this particular study, the analysis has allowed the NASA team to quickly eliminate certain mission alternatives from consideration. Overall, our experience indicates that approaches such as TIMA can play a valuable role in lifecycle management of complex technology portfolios.
